Title
Category
Credits
Event date
Cost
  • CME Activities
  • Critical Care
  • Emergency
  • Neurology
  • Nursing Continuing Education
  • Stroke
  • Tenecteplase
  • Thrombolytics
  • Nursing Education Hours
  • Participation
$0.00
Intravenous thrombolytics is the mainstay of acute therapy in ischemic stroke.  While alteplase has been FDA-approved for this indication since the 1990s, Tenecteplase has recently gained traction for usage in acute ischemic stroke treatment as well.  This lecture summarizes the existing evidence and practical considerations for use of Tenecteplase in stroke therapy.  
  • Alteplase
  • Best Practices
  • Critical Care
  • Emergency
  • Epilepsy
  • Neurology
  • Nursing Continuing Education
  • Stroke
  • Tenecteplase
  • Thrombolytics
  • Nursing Contact Hours
$0.00
Join TeleSpecialists Dr. Theresa Sevilis, board certified vascular neurologist to review the American Heart Association Guidelines for the Early Management of Patients with Acute Ischemic Stroke.  Dr. Sevilis will discuss the indications, relative contraindications, and absolute contraindications for thrombolytics, provide cases for review, and discuss how to use the Guidelines in the decision making process.  She will highlight the most commonly asked questions surrounding thrombolytic administration and discuss the new utilization of tenecteplase in place of alteplase.